Novel mechanisms for Alzheimer disease prevention and or treatment
Project Number1I01BX004202-01A1
Contact PI/Project LeaderPUGLIELLI, LUIGI
Awardee OrganizationWM S. MIDDLETON MEMORIAL VETERANS HOSP
Description
Abstract Text
PROBLEM: Aging is the most important risk factor for Alzheimer's disease (AD), which represents the
most common cause of dementia in our country. The disease, for which there is no currently available
treatment, is becoming increasingly prevalent among our aging veteran population.
PRELIMINARY DATA: Autophagy is an essential component of the cell degrading machinery. It helps
dispose of large toxic protein aggregates that form within the secretory pathway and in the cytosol.
Malfunction of autophagy and disruption of proteostasis contributes to the progression of many chronic
diseases. In addition, many chronic degenerative diseases are characterized by the aberrant accumulation
of toxic protein aggregates. Compelling data indicate that increased levels of autophagy can be beneficial in
mouse models of diseases characterized by increased accumulation of toxic protein aggregates, including
AD. As such, improving normal proteostatic mechanisms is an active target for biomedical research. Nε-
lysine acetylation was initially thought to occur only in the cytoplasm and nucleus. However, in 2007 we
discovered that the endoplasmic reticulum (ER) is also able to acetylate newly-synthesized polypeptides.
Since then, we have successfully identified the entire biochemical machinery responsible for ER-acetylation
and generated relevant animal models. The machinery includes AT-1, which translocates acetyl-CoA from
the cytosol to the ER lumen, and ATase1/ATase2, two acetyltransferases that carry out the enzymatic
reaction within the ER lumen. We discovered that the ER acetylation machinery maintains the homeostatic
balance of two essential and intimately related functions of the ER: (i) “positive” selection of correctly folded
nascent polypeptides and (ii) tight regulation of autophagy/reticulophagy. Mice with reduced influx of acetyl-
CoA into the ER (AT-1S113R/+) display excessive induction of autophagy and a block of the secretory pathway
while mice with increased influx (AT-1 Tg and AT-1 sTg) display increased efficiency of the secretory
pathway and a block of normal reticulophagy. In both cases, lack of homeostatic balance leads to drastic
phenotypes. Relevant to this proposal is also the fact that a dysfunctional ER acetylation machinery has
been linked to aging and AD. Consistently, haploinsufficiency of AT-1 or biochemical inhibition of the
ATases was able to rescue the AD-like phenotype in the mouse.
HYPOTHESIS: Our general hypothesis is that the ER acetylation machinery ensures protein
homeostasis. Deregulation of this cross-talk impacts both aging and AD.
STUDY DESIGN: Specific Aim 1 will identify novel structure-based ATase1 and ATase2 inhibitors to
prevent AD. This Aim will take advantage of new structural information that we have collected on the
ATases and new structure-based inhibitors that we have recently identified. Relevant structural
biochemistry, in vitro and ex vivo analysis, and pre-formulation/formulation development of these novel
compounds have already been completed. They will now be tested in two mouse models of AD. This Aim
will also take advantage of ATase1-/- and ATase2-/- mice, recently generated in our laboratory to determine
whether targeting only one ATase is sufficient to rescue AD neuropathology in the mouse. Specific Aim 2
will identify the molecular mechanism(s) that provides specificity to the proteostatic functions of the ER
acetylation machinery. Under this Aim we report the identification of a novel ER-based acetyltransferase
that appears to play an important role in the regulation of autophagy/reticulophagy down-stream of the ER
acetylation machinery. This Aim is highly mechanistic and includes a combination of structural biochemistry,
molecular biology and in vitro/ex vivo analysis.
Public Health Relevance Statement
Our group has recently discovered a new biochemical machinery that is implicated with the pathogenesis of
Alzheimer’s disease (AD). As a continuation of our efforts, we have identified structural details and
pharmacologic compounds that target the above machinery and prevent AD-related events in cellular and
animal models of the disease. Therefore, our studies are leading the field toward new directions that, if
successful, will have direct impact on the prevention of a disease that is projected to affect nearly 15 million
Americans by the year 2050. This particular project has direct relevance for the research and clinical
priorities of the Dept. of Veterans Affairs, and will have impact on our abilities to respond to the dramatic rise
of AD dementia among the aging veteran population and to improve the quality of care to the aged. Finally,
the long-term goal of this project is consistent with the mission of the Geriatric Research, Education and
Clinical Center (GRECC) of this VA Hospital.
No Sub Projects information available for 1I01BX004202-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1I01BX004202-01A1
Patents
No Patents information available for 1I01BX004202-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1I01BX004202-01A1
Clinical Studies
No Clinical Studies information available for 1I01BX004202-01A1
News and More
Related News Releases
No news release information available for 1I01BX004202-01A1
History
No Historical information available for 1I01BX004202-01A1
Similar Projects
No Similar Projects information available for 1I01BX004202-01A1